Masimo MASI announced that the FDA has granted De Novo status to its noninvasive, continuous parameter — ORi (Oxygen Reserve Index) — designed to provide additional insight into a patient’s oxygen ...
Without ORi, there is no noninvasive way to monitor oxygenation under supplemental oxygen to manage hyperoxia, or higher than normal oxygenation of arterial blood. There is growing evidence that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback